New-onset refractory status epilepticus after first dose of tozinameran
Document Type
Article
Publication Date
9-1-2022
Abstract
As the worldwide vaccination effort against COVID-19 gains traction, complications attributed to the vaccines are increasingly reported in medical literature. Herein, we describe the first two cases of new-onset refractory status epilepticus after receiving their first doses of tozinameran. These were attributed to underlying autoimmune responses against the vaccine given the temporal proximity to them receiving tozinameran, the absence of alternative diagnoses, the refractoriness of their seizures, and their clinical improvement only after administration of immunotherapies. Importantly, their cases supplement existing reports on the rare neurologic complications of the COVID-19 vaccines and continued the amidst the
Keywords
NORSE, COVID-19, Vaccination, Status epilepticus, Encephalitis
Divisions
fac_med
Publication Title
Neurology Asia
Volume
27
Issue
3
Publisher
ASEAN Neurological Association
Publisher Location
UNIV MALAYA MEDICAL CENTRE, NEUROLOGY LABORATORY, KUALA LUMPUR, 59100, MALAYSIA